Epizyme Inc (NASDAQ:EPZM)
| 2.02 Delayed Data As of Jan 24 |  -0.05 / -2.42%Today’s Change | 1.84 Today|||52-Week Range 12.37 | -19.20% Year-to-Date |
Latest EPZM News | Press Releases
No recent news for Epizyme Inc.
Today’s Trading
| Previous close | 2.07 |
| Today’s open | 2.00 |
| Day’s range | 1.85 - 2.00 |
| Volume | 82,773 |
| Average volume (3 months) | 1,412,315 |
| Market cap | $216.1M |
Data as of 4:03pm ET, 01/24/2022
Growth & Valuation
| Earnings growth (last year) | -19.08% |
| Earnings growth (this year) | -5.76% |
| Earnings growth (next 5 years) | +38.00% |
| Revenue growth (last year) | -33.77% |
| P/E ratio | NM |
| Price/Sales | 69.56 |
| Price/Book | 1.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| IMMPImmutep Ltd | -0.19 | -6.67% |
| AGLEAeglea Bio Therapeut... | +0.16 | +3.70% |
| CODXCo-Diagnostics Inc | -0.19 | -2.54% |
| MGTAMagenta Therapeutics... | -0.07 | -2.10% |
Data as of 4:02pm ET, 01/24/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $15.8M |
| Annual profit (last year) | -$231.7M |
| Net profit margin | -1,469.95% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
